July « 2022 « Science and Enterprise

Infographic – Fewer in US See Covid-19 Threat

By Alan, on July 30th, 2022%

The percentage of Americans viewing Covid-19 as a major threat to public health is declining, with a majority now saying the disease is a minor or no threat at all. . . . → Read More: Infographic – Fewer in US See Covid-19 Threat

Biotech Start-Up Demonstrates Cancer Therapy, Raises $6.4M

By Alan, on July 29th, 2022%

A new biotechnology company demonstrated in lab mice its therapy for glioblastoma, an aggressive brain cancer, that overcomes limitations of current treatments. . . . → Read More: Biotech Start-Up Demonstrates Cancer Therapy, Raises $6.4M

Women’s Health Companies Partner on New Contraceptive

By Alan, on July 28th, 2022%

Two companies working in women’s reproductive health are developing a new non-hormonal contraceptive that works in cervical mucous membranes. . . . → Read More: Women’s Health Companies Partner on New Contraceptive

Biotechs Discover Antimicrobial Peptide for Food Safety

By Alan, on July 27th, 2022%

Two biotechnology companies say they discovered a peptide molecule with antimicrobial properties for faster identification and containment of food contamination outbreaks. . . . → Read More: Biotechs Discover Antimicrobial Peptide for Food Safety

Small Biz Grant Funds Non-Viral Gene Editing Delivery

By Alan, on July 26th, 2022%

National Institutes of Health is financing a delivery method for gene-editing therapies to blood-forming stem cells with natural lipid bubbles instead of viruses. . . . → Read More: Small Biz Grant Funds Non-Viral Gene Editing Delivery

Ginkgo Acquires Biomaterials Maker as Industry Consolidates

By Alan, on July 25th, 2022%

A developer of synthetic biology tools and components is acquiring a biological materials developer for its automation assets as the biotechnology industry consolidates. . . . → Read More: Ginkgo Acquires Biomaterials Maker as Industry Consolidates

Infographic – Digital Health Keeps Clicking in 2022

By Alan, on July 23rd, 2022%

While venture capital funding for digital health start-ups worldwide is down compared to last year, the pace so far in 2022 remains on an historically strong track. . . . → Read More: Infographic – Digital Health Keeps Clicking in 2022

AI System Shown to Provide Early Sepsis Warnings

By Alan, on July 22nd, 2022%

A system using machine learning algorithms is shown to provide early warnings about sepsis developing in hospitalized patients, reducing injury and death. . . . → Read More: AI System Shown to Provide Early Sepsis Warnings

Trial Okayed for Engineered Cell Cancer Therapy

By Alan, on July 21st, 2022%

A clinical trial is set to begin testing engineered immune-system cells designed to precisely target and infiltrate cancerous tumors without other potentially toxic proteins. . . . → Read More: Trial Okayed for Engineered Cell Cancer Therapy

Trial Shows Oral Covid-19 Vaccine Produces Antibodies

By Alan, on July 20th, 2022%

A clinical trial shows a Covid-19 vaccine taken as a tablet produces protective antibodies in nasal membranes that in some cases last for up to a year. . . . → Read More: Trial Shows Oral Covid-19 Vaccine Produces Antibodies

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise